[HTML][HTML] Personalising medicine in inflammatory bowel disease—current and future perspectives

JJ Ashton, E Mossotto, S Ennis… - Translational …, 2019 - ncbi.nlm.nih.gov
Up to 25% of inflammatory bowel disease (IBD) presents during childhood, often with severe
and extensive disease, leading to significant morbidity including delayed growth and …

The impact of the interleukin 12/23 inhibitor ustekinumab on the risk of infections in patients with psoriatic arthritis

A Zabotti, D Goletti, E Lubrano… - Expert Opinion on Drug …, 2020 - Taylor & Francis
ABSTRACT Introduction: Psoriatic arthritis (PsA) is characterized by chronic inflammation
mediated by pro-inflammatory cytokines, with clinical features resulting from dysfunctional …

Corticosteroids and infliximab impair the performance of interferon-γ release assays used for diagnosis of latent tuberculosis

A Edwards, Y Gao, RN Allan, D Ball, H De Graaf… - Thorax, 2017 - thorax.bmj.com
The impact of immunosuppression on interferon-γ release assays and novel cytokine
biomarkers of TB infection, mycobacteria-specific IL-2, IP-10 and TNF-α responses was …

[HTML][HTML] Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus …

DH Jeong, J Kang, YJ Jung, B Yoo, CK Lee, YG Kim… - PLoS …, 2018 - journals.plos.org
This study aims to compare the latent tuberculosis infection (LTBI) screening strategy of
interferon-gamma release assay (IGRA)-alone and in combination with tuberculin skin tests …

Prevalence and management of tuberculosis infection in Apulian rheumatologic patients treated with biologics: An observational cohort 10‐year study from the …

M Fornaro, S Stano, D Goletti… - European Journal of …, 2023 - Wiley Online Library
Introduction The objective of this study was to assess the 10‐year prevalence of latent
tuberculosis infection (LTBI) among Apulian patients with rheumatic diseases (RDs) …

Limitations of current tuberculosis screening tests in immunosuppressed patients

V Clifford, M Tebruegge… - BMJ: British Medical …, 2015 - search.proquest.com
Interestingly, we found that interferon [GAMMA] inducible protein 10 was a more sensitive
marker of latent tuberculosis in the presence of dexamethasone, 4 which is consistent with a …

[PDF][PDF] Does dermatoradiology exist?

C Tagliati, G Rizzetto, E Molinelli… - Acta …, 2024 - acta-apa.mf.uni-lj.si
We would like to express our thoughts about ultrasound in dermatology and about the
interconnections between dermatology and radiology in actual daily clinical practice …

Conversion of tuberculosis screening tests during biologic therapy among veteran patient population with rheumatic disease

D Pattanaik, S Gupta, S Islam… - ACR Open …, 2019 - Wiley Online Library
Objective The optimal strategy to detect the development of tuberculosis (TB) in subjects
receiving biologic agents is not clear. The recommendations vary because there is wide …

Personalised medicine in IBD: don't dispose of the sledgehammer just yet

A Kumar, MJ Brookes, JP Segal - Therapeutic Advances in …, 2022 - journals.sagepub.com
Personalised medicine in IBD: don’t dispose of the sledgehammer just yet - Aditi Kumar, Matthew
J Brookes, Jonathan P Segal, 2022 Skip to main content Intended for healthcare professionals …

Tumour Necrosis Factor Antagonists

L Chularojanamontri, CEM Griffiths - Handbook of Systemic Drug …, 2023 - taylorfrancis.com
The tumour necrosis factor (TNF) family is a group of 19 cytokines that produce
inflammation, apoptosis, proliferation and angiogenesis. Golimumab induces a weaker …